These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4601358)

  • 1. Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.
    Shimizu T; Kondo H
    Jpn J Med Sci Biol; 1973 Dec; 26(5):269-71. PubMed ID: 4601358
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of antibody to each component of Clostridium botulinum type E progenitor toxin.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1973 Dec; 26(5):187-95. PubMed ID: 4601357
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic and chromatographic identity of two apparently distinct toxins of Clostridium botulinum type A.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1969 Oct; 15(10):1129-32. PubMed ID: 4905857
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 5. The partial reactivation of formalin-inactivated Clostridium botulinum type C toxin.
    MARTY EW
    Am J Vet Res; 1961 Jul; 22():770-4. PubMed ID: 13767602
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of prednisolone, periston-N and antitoxic serum on the absorption and localization of I-131-labelled Clostridium botulinum B toxin in guinea pigs].
    Stempień R; Fabianowski J; Ubysz-Jerzmanowska K; Brühl A
    Pol Tyg Lek; 1967 May; 22(18):665-8. PubMed ID: 4865249
    [No Abstract]   [Full Text] [Related]  

  • 8. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 10. [A study of the kinetics of detoxication of purified type A botulinum toxin by formalin].
    VASIL'EV NN
    Biokhimiia; 1961; 26():667-72. PubMed ID: 13780379
    [No Abstract]   [Full Text] [Related]  

  • 11. Phagocytosis of staphylococci by mouse leukocytes in the presence of botulinum toxin.
    FREEMAN NL
    J Bacteriol; 1961 Jan; 81(1):156-7. PubMed ID: 13701643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research in vitro on toxigenesis of Cl. tetani and Cl. botulinum].
    D'ARCA SIMONETTI A
    Nuovi Ann Ig Microbiol; 1959; 10():342-58. PubMed ID: 13813594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clostridium botulinum type-E toxin].
    Sakaguchi G
    Nihon Saikingaku Zasshi; 1968 Mar; 23(3):155-64. PubMed ID: 4877828
    [No Abstract]   [Full Text] [Related]  

  • 15. Titration of kappa toxin of Clostridium perfringens and kappa antitoxin by a modified azocoll method.
    Kameyama S; Akama K
    Jpn J Med Sci Biol; 1970 Feb; 23(1):31-46. PubMed ID: 4317539
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antigenic structure of the toxins of Clostridium botulinum, type C strains, isolated in the USSR].
    Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Aug; 42(8):79-84. PubMed ID: 5334428
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the amount of sorbent on the immunogenic property of botulin anatoxins].
    LABINSKII AP
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Feb; 33():78-84. PubMed ID: 14461267
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.